Low Wang has found that patients do well if they pay close attention to when they start feeling full and stop eating at that point
Finding the Right Needle Depth for Your Skin MDPen devices offer adjustable penetration depth from 0.1mm to 2.5mm, giving trained practitioners precise control matched to the tissue depth required
In addition, Lilly has reported data suggesting that patients transitioning from injectable incretin therapies to oral GLP-1 treatment were able to maintain weight loss in late-stage studies
AOD-9604 produces modest weight loss (2-3 kg over 12 weeks in trials) through peripheral fat tissue activation without any appetite effects
For example, niches may be created by addressing specific unmet needs in certain patient types (e.g., patients who prefer not to inject, or who failed prior lines of GLP-1s), or by addressing specific access issues (e.g., developing a lower-cost option, securing broader payer coverage)